Chinese vaccine developer CanSino Biologics is in talks with Russia, Brazil, Chile and Saudi Arabia to launch a Phase III trial of its experimental COVID-19 vaccine
China's CanSino in talks with Russia, Brazil, Chile for Phase III trials of vaccine
Advertisment
STORY HIGHLIGHTS
Advertisment